Table 2.
Framework A input data and results for phases I and II with zero selfishness
| Specialty | Additional cost1 | Demand2 | Capacity2 | Atcama | Valparaiso3 | Osorno | Total PH I & II | |||
|---|---|---|---|---|---|---|---|---|---|---|
| PH I | PH II | PH I | PH II | PH I | PH II | |||||
| Adult SX | 18 | 80 | 14 | 0 | 0 | 1 | 13 | 0 | 0 | 14 |
| Anesthesiology | 18 | 24 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| Breast SX | 18 | 0 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bronchopulmonary | 0 | 15 | 19 | 0 | 0 | 9 | 0 | 0 | 6 | 15 |
| Cardiology | 0 | 46 | 26 | 0 | 12 | 14 | 0 | 0 | 0 | 26 |
| Cardiovascular SX | 0 | 14 | 6 | 0 | 0 | 1 | 0 | 0 | 5 | 6 |
| Dentistry | 18 | 525 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dermatology | 16 | 15 | 77 | 0 | 0 | 0 | 0 | 0 | 15 | 15 |
| Endocrinology | 0 | 6 | 8 | 0 | 0 | 2 | 0 | 0 | 4 | 6 |
| Family Medicine | 29 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gastroenterology | 0 | 14 | 25 | 3 | 0 | 10 | 1 | 0 | 0 | 14 |
| Genetics | 0 | 4 | 24 | 0 | 0 | 0 | 4 | 0 | 0 | 4 |
| Hematology | 0 | 23 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 2 |
| Infectious Disease | 0 | 5 | 6 | 0 | 5 | 0 | 0 | 0 | 0 | 5 |
| Internal Medicine | 0 | 60 | 110 | 16 | 0 | 39 | 5 | 0 | 0 | 60 |
| Maxillofacial SX | 0 | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nephrology | 10 | 11 | 18 | 0 | 0 | 3 | 0 | 0 | 8 | 11 |
| Neurology | 0 | 86 | 51 | 12 | 0 | 23 | 0 | 0 | 16 | 51 |
| Neurosurgery | 0 | 37 | 22 | 0 | 0 | 13 | 4 | 0 | 5 | 22 |
| Nutrition | 19 | 5 | 4 | 0 | 0 | 4 | 0 | 0 | 0 | 4 |
| Gynecology | 18 | 102 | 231 | 9 | 0 | 28 | 0 | 0 | 65 | 102 |
| Oncology | 0 | 26 | 4 | 0 | 0 | 0 | 4 | 0 | 0 | 4 |
| Ophtalmology | 0 | 483 | 215 | 164 | 0 | 1 | 50 | 0 | 0 | 215 |
| Other | 18 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| ENT | 16 | 26 | 284 | 6 | 0 | 15 | 5 | 0 | 0 | 26 |
| Pediatrics | 4 | 10 | 27 | 1 | 0 | 0 | 0 | 0 | 9 | 10 |
| Physical Medicine | 10 | 0 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Plastic SX | 18 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Proctological SX | 10 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Psychiatry | 7 | 8 | 57 | 0 | 0 | 8 | 0 | 0 | 0 | 8 |
| Rheumatology | 24 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sexual Diseases | 24 | 23 | 5 | 0 | 0 | 0 | 5 | 0 | 0 | 5 |
| Traumatology | 24 | 39 | 169 | 0 | 0 | 0 | 0 | 0 | 39 | 39 |
| Urology | 10 | 53 | 111 | 0 | 0 | 0 | 36 | 0 | 17 | 53 |
| Total | 1972 | 1596 | 211 | 17 | 174 | 127 | 0 | 190 | 719 | |
| % of Demand | 100 | 80.93 | 52.36 | 8.9 | 18.1 | 16.1 | 0 | 31.3 | 36.46 | |
Abbreviations: PH, phase; SX, surgery; ENT, ear, nose, and throat; PH I, local transfers; PH II, regional transfers
1 Additional cost of diagnosis in the private network in US dollars
2 Average monthly values
3 Valparaiso-San Antonio regional health service